Table 3 Marginal effect expenses estimates in patients with arterial hypertension according level physical active in a adjusted analyse.
Marginal effects (US$) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Consultation (adjusted) | Laboratory tests (adjusted) | Medication (adjusted) | Total primary care (adjusted) | Total sec. and terc. care (adjusted) | |||||||||||||
Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95%ICI] | Estim. (S.E) | [95% CI] | Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95% CI] | ||||||||
NOR + ACTIVE (reference) (n = 31) | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |||||||
NOR + IA (n = 69) | 6.48 (4.76) | -2.85; 15.8 | -2.83 (2.52) | -7.79; 2.12 | 12.23 (7.08) | -1.65; 26.12 | 12.6 (9.70) | -6.38; 31.6 | -1.16 (205.2) | -403.4; 401.1 | |||||||
AH + ACTIVE (n = 51) | 13.4* (6.15) | 1.34; 25.4 | 2.47 (3.48) | -4.35; 9.30 | 10.8 (7.83) | -4.53; 26.1 | 23.7 (1.1) | -0.10; 47.5 | 121.6 (247.3) | -363.0; 606.3 | |||||||
AH + IA (n = 156) | 20.0** (5.20) | 9.90; 30.2 | -0.08 (2.69) | -5.36; 5.18 | 34.2** (7.82) | 18.9; 49.5 | 51.6** (10.8) | 30.2; 72.9 | 254.1 (255.7) | -188.4; 696.6 | |||||||
Confounding variables | |||||||||||||||||
Gender (female) | 11.6** (4.20) | 3.36; 19.8 | 1.39 (1.46) | -1.47; 4.26 | -5.59 (6.93) | -19.1; 7.99 | 10.9 (8.49) | -5.71; 27.6 | -163.8 (130.7) | -420.1; 92.4 | |||||||
Age | 0.27 (0.24) | -0.21; 0.75 | 0.11 (0.91) | -0.06; 0.29 | 0.40 (0.44) | -0.47; 1.28 | 0.67 (0.52) | -0.35; 1.71 | 1.62 (8.02) | -14.1; 17.3 | |||||||
WC | -0.01 (0.13) | -0.27; 0.23 | -0.02 (0.04) | -0.12; 0.06 | 0.10 (0.27) | -0.43; 0.64 | 0.06 (0.30) | -0.53; 0.65 | -6.03 (4.90) | -15.6; 3.57 | |||||||
Sum of diseases | 12.7* (5.29) | 2.37; 23.1 | 1.28 (1.77) | -2.18; 4.76 | 25.8** (10.0) | 6.17; 45.6 | 38.1** (11.4) | 15.7; 60.5 | 128.8 (168.2) | -200.8; 458.4 | |||||||